(EMAILWIRE.COM, August 09, 2018 ) The report "European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020", analyzes and studies the major market drivers, restraints, opportunities, and challenges in Europe.

Browse 67 market data tables and 12 figures spread through 222 pages and in-depth TOC on “European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease (Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020"

http://www.marketsandmarkets.com/Market-Reports/european-ngs-services-market-264072127.html

Early buyers will receive 10% customization on reports.

The NGS services market in Europe is expected to reach USD 1,152 Million by 2020 from USD 444 Million in 2015, at a CAGR of 21% from 2015 to 2020.

Download Report Brochure:- http://www.marketsandmarkets.com/pdfdownload.asp?id=264072127

The report segments the European NGS services market on the basis of technology, application, end user, disease type, and country. Major applications of NGS services include whole-genome sequencing, exome sequencing, targeted sequencing/gene panels,
De novo sequencing, RNA-seq, ChiP-seq, and methyl-seq. The exome sequencing application segment is forecasted to be the fastest-growing segment during the forecast period. The exome and untranslated regulatory regions (UTRs) comprise only 1% to 2% of the human genome, yet contain as many as 85% of disease-related mutations and thus exome sequencing is considered as one of the important tools in NGS. Also, exome sequencing requires less time and resources and enables producing results at a low cost and greater speed and resolution.

Regionally, the market is segmented into the U.K., Germany, France, Italy, Spain, Netherlands, and Rest of the Europe (RoE). The U.K. is estimated to account for the largest share of the European NGS services market in 2015 and is also poised to be the fastest-growing region during the forecast period.

For more Details Speak to Analyst :- http://www.marketsandmarkets.com/speaktoanalyst.asp?id=264072127

Key players in the European NGS services market include the Beijing Genomics Institute (BGI) (China), Macrogen (South Korea), Eurofins Genomics (Germany), Illumina (U.S.), DNA Vision (Belgium), CeGaT GmbH (Germany), Febit (U.S.), Genomnia (Italy), Microsynth (Switzerland), and Source Bioscience (U.K.).